Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 22522050 approvals

GENOLUTION INC.

Official website

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

Price

Change

Market cap

Products & technology

  • Nucleic acid extraction reagent kits (STD, HBV, HPV, TB/NTM, RV)Extracting nucleic acids (RNA/DNA) from human-derived samples
  • NX-48N, NX-DUO, NX-Junior, NX-32NAutomated nucleic acid extraction devices
  • long dsRNA synthesis productsSynthetic dsRNA for RNAi gene-silencing research
  • shRNA/siRNA synthesis serviceSynthesis service for RNAi research

Regulatory approvals

data.go.kr

50 Korean MFDS device approvals · 2013–2025

  • MFDSIVD reagents for extracting nucleic acids2025-07-08
    Product approval · Class 1체외 제신 25-867 호
  • MFDSIVD reagents for extracting nucleic acids2025-07-08
    Product approval · Class 1체외 제신 25-866 호
  • MFDSIVD reagents for extracting nucleic acids2025-07-08
    Product approval · Class 1체외 제신 25-865 호
  • MFDSIVD reagents for extracting nucleic acids2025-07-08
    Product approval · Class 1체외 제신 25-864 호
  • MFDSIVD reagents for extracting nucleic acids2025-03-11
    Product approval · Class 1체외 제신 25-296 호
  • MFDSIVD reagents for extracting nucleic acids2024-12-13
    Product approval · Class 1체외 제신 24-1555 호
  • MFDSIVD reagents for extracting nucleic acids2024-10-31
    Product approval · Class 1체외 제신 24-1338 호
  • MFDSIVD reagents for extracting nucleic acids2024-02-27
    Product approval · Class 1체외 제신 24-248 호
  • MFDSIVD reagents for extracting nucleic acids2024-02-20
    Product approval · Class 1체외 제신 24-216 호
  • MFDSIVD reagents for extracting nucleic acids2023-11-30
    Product approval · Class 1체외 제신 23-1708 호
  • MFDSExtractor, nucleic acid2023-09-27
    Product approval · Class 1체외 제신 23-1453 호
  • MFDSIVD reagents for extracting nucleic acids2023-09-20
    Product approval · Class 1체외 제신 23-1409 호
Show 38 more
  • MFDSIVD reagents for extracting nucleic acids2023-09-20
    Product approval · Class 1체외 제신 23-1406 호
  • MFDSIVD reagents for extracting nucleic acids2023-08-16
    Product approval · Class 1체외 제신 23-1243 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-932 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-931 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-929 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-928 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-924 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-16
    Product approval · Class 1체외 제신 23-923 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-07
    Product approval · Class 1체외 제신 23-895 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-07
    Product approval · Class 1체외 제신 23-894 호
  • MFDSIVD reagents for extracting nucleic acids2023-06-07
    Product approval · Class 1체외 제신 23-893 호
  • MFDSIVD reagents for extracting nucleic acids2023-04-17
    Product approval · Class 1체외 제신 23-658 호
  • MFDSIVD reagents for extracting nucleic acids2023-04-17
    Product approval · Class 1체외 제신 23-655 호
  • MFDSIVD reagents for extracting nucleic acids2023-04-07
    Product approval · Class 1체외 제신 23-626 호
  • MFDSIVD reagents for extracting nucleic acids2023-04-07
    Product approval · Class 1체외 제신 23-625 호
  • MFDSIVD reagents for extracting nucleic acids2023-04-07
    Product approval · Class 1체외 제신 23-624 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1483 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1482 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1481 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1480 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1479 호
  • MFDSIVD reagents for extracting nucleic acids2022-10-26
    Product approval · Class 1체외 제신 22-1478 호
  • MFDSExtractor, nucleic acid2022-09-22
    Product approval · Class 1체외 제신 22-1319 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-618 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-617 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-616 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-615 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-614 호
  • MFDSIVD reagents for extracting nucleic acids2022-05-04
    Product approval · Class 1체외 제신 22-613 호
  • MFDSIVD reagents for extracting nucleic acids2022-02-09
    Product approval · Class 1체외 제신 22-171 호
  • MFDSIVD reagents for extracting nucleic acids2022-02-09
    Product approval · Class 1체외 제신 22-169 호
  • MFDSExtractor, nucleic acid2022-01-19
    Product approval · Class 1체외 제신 22-88 호
  • MFDSExtractor, nucleic acid2021-09-28
    Product approval · Class 1체외 제신 21-1296 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnostics2015-01-16
    Product approval · Class 3체외 제허 15-60 호
  • MFDSIVD reagents for extracting nucleic acids2014-09-12
    Product approval · Class 1서울 체외 제신 14-360 호
  • MFDSIVD reagents for extracting nucleic acidsRevoked2014-01-24
    Product approval · Class 1서울 체외 제신 14-54 호
  • MFDSExtractor, nucleic acid2014-01-24
    Product approval · Class 1경인 체외 제신 14-66 호
  • MFDSIVD reagents for extracting nucleic acids2013-08-08
    Product approval · Class 1서울 체외 제신 13-221 호

R&D and key agreements

Source: DART corporate disclosure

마그네틱 비드 관련 특허 · 특허출원 · Filed a patent related to magnetic beads, a key raw material for nucleic acid extraction reagents, to reduce costs.

전자동 분자진단 장비 · 개발중 · Developing a fully automated molecular diagnostic device covering the process from sample input to PCR preparation.

Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsPharma & CDMO

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

BIONEERCORPORATION3 shared

Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.

Boditech Med Inc.3 shared

KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.

CALTH. Inc3 shared

Holds manufacturing approvals for 42 point-of-care diagnostic reagents and devices in the IVD market.

Genesystem Co., Ltd3 shared

Founded 2010, listed on KOSDAQ in 2021, Genesystem develops molecular diagnostic systems, biochips, test kits, and reaction reagents.

HLB PANAGENE Co., LTD.3 shared

Founded in 1976 and KOSDAQ-listed in 2000, HLB PANAGENE develops PNA-based molecular diagnostic and diagnostic automation products.

iNtRON Biotechnology, Inc.3 shared

Founded in 1999 and listed on KOSDAQ in 2011, iNtRON Biotechnology develops bacteriophage-based new drugs via its itLysin and IMPA platforms alongside a molecular diagnostics business.

OSANG HEALTHCARE CO.,LTD.3 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

RollingStone Co., Ltd.3 shared

KOSDAQ-listed in-vitro diagnostics company developing the LabChip-based VERI-Q molecular diagnostic device series.

SEEGENE, INC.3 shared

Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.

GC Medical Science Corporation2 shared

GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.

Gencurix Inc.2 shared

Founded 2011, KOSDAQ-listed 2020, Gencurix develops liquid-biopsy diagnostics: breast cancer prognosis and lung/colorectal companion tests.

NanoenTek,Inc.2 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

Sources and updates

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
AI visibility
Measured 2026-08-13

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition